Myocardial Infarction Research

Myocardial infarction (MI) - more commonly referred to as a heart attack - is an acute event caused by the interruption of blood supply to regions of the heart, leading to myocardial necrosis. Infarction of a substantial area of the myocardium can disrupt normal conductance of the heart, leading to cardiac arrest.In the majority of cases, an MI is immediately preceded by the presence of an occlusive thrombus within a coronary artery, blocking blood flow to the downstream tissue. The most common cause of an occlusive thrombus within a coronary artery is the rupture of an atherosclerotic plaque. However, the occlusion of a coronary artery may also result from coronary embolism. This can occur in patients following stent placement, angioplasty, and coronary artery bypass grafting.

Myocardial Infarction Research Products Targets

Products for Myocardial Infarction Research - Page 21

  1. Cat.No. Product Name Information/Activity
  2. BCC7240 PSB 36 524944-72-7 PSB 36 chemical structure
  3. BCC7656 SLV 320 Derenofylline (SLV 320) is a potent, selective and orally active adenosine A1 receptor antagonist, with Ki values of 1 nM, 200 nM and 398 nM for human A1, A3 and A2A receptors respectively. Derenofylline suppresses cardiac fibrosis and attenuates albuminuria without affecting blood pressure in rats. SLV 320 chemical structure
  4. BCC7032 PD 81723 132861-87-1 PD 81723 chemical structure
  5. BCC4316 CGS 21680 HCl CGS 21680 Hydrochloride is a selective adenosine A2A receptor agonist with a Ki of 27 nM. CGS 21680 HCl chemical structure
  6. BCC7163 CV 1808 53296-10-9 CV 1808 chemical structure
  7. BCC6237 LUF 5834 333962-91-7 LUF 5834 chemical structure
  8. BCC7640 8-(3-Chlorostyryl)caffeine 147700-11-6 8-(3-Chlorostyryl)caffeine chemical structure
  9. BCC7815 ANR 94 Adenosine A<sub>2A </sub>antagonist ANR 94 chemical structure
  10. BCC3798 Istradefylline (KW-6002) Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson's disease. Istradefylline (KW-6002) chemical structure
  11. BCC7977 Lu AA 47070 913842-25-8 Lu AA 47070 chemical structure

Items 201 to 210 of 400 total